S&P ASX All Technology

3,045.20

-2.07%

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Rxi Pharmaceuticals Corp. (MM) (RXII)
Rxi Pharmaceuticals Corp. (MM) (RXII) News

RXII

RXI Pharmaceuticals Corporation (RXII)

Rxi Pharmaceuticals Corp. (MM)

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:RXII

1 2 3 4 5 6 7 8 9 10 Next >>

Date	Time	Source	Headline	Symbol	Company
15/02/2019	23:15	PR Newswire (US)	Phio Pharmaceuticals Appoints Gerrit Dispersyn as New Chief Executive Officer Effective March 1	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
11/12/2018	01:35	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
27/11/2018	01:30	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
20/11/2018	09:52	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
14/11/2018	23:12	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
14/11/2018	23:10	PR Newswire (US)	RXi Pharmaceuticals Reports Third Quarter 2018 Financial Results and Recent Corporate Highlights	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
14/11/2018	23:08	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
14/11/2018	09:31	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
14/11/2018	01:26	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
07/11/2018	23:05	PR Newswire (US)	RXi Pharmaceuticals to Present New Data Demonstrating the Ability of sd-rxRNA to Enhance NK Cell Activity for Adoptive Cell T...	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
06/11/2018	23:05	PR Newswire (US)	RXi Pharmaceuticals to Webcast Third Quarter 2018 Financial Results on Wednesday, November 14, 2018	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
30/10/2018	00:28	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
16/10/2018	00:26	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
11/10/2018	05:00	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
06/10/2018	07:04	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
04/10/2018	06:31	PR Newswire (US)	RXi Pharmaceuticals Announces Closing Of $15 Million Underwritten Public Offering	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
03/10/2018	07:32	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
03/10/2018	07:30	Edgar (US Regulatory)	Post-effective Amendment Filed Solely to Add Exhibits to a Registration Statement (pos Ex)	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
02/10/2018	02:42	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
01/10/2018	20:39	Edgar (US Regulatory)	Registration of Additional Securities (up to 20%) (s-1mef)	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
01/10/2018	20:36	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
01/10/2018	20:10	PR Newswire (US)	RXi Pharmaceuticals Announces Pricing Of $15 Million Upsized Underwritten Public Offering	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
28/09/2018	20:14	Edgar (US Regulatory)	Securities Registration Statement (s-1/a)	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
26/09/2018	22:01	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
26/09/2018	22:00	PR Newswire (US)	RXi Pharmaceuticals to Present New Data from its Immuno-Oncology Program Using sd-rxRNA Therapeutic Compounds Targeting Intra...	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
15/09/2018	07:48	Edgar (US Regulatory)	Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
15/09/2018	07:48	Edgar (US Regulatory)	Securities Registration Statement (s-1/a)	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
04/09/2018	21:06	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
01/09/2018	07:32	Edgar (US Regulatory)	Securities Registration Statement (s-1)	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
28/08/2018	23:15	PR Newswire (US)	RXi Pharmaceuticals to Present at the 20th Annual Rodman & Renshaw Global Investment Conference	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)